From Surf Wiki (app.surf) — the open knowledge base
5-MeO-NMT
| Field | Value | |||
|---|---|---|---|---|
| Verifiedfields | changed | |||
| Watchedfields | changed | |||
| verifiedrevid | 477225048 | |||
| image | 5-MeO-NMT.svg | |||
| image_class | skin-invert-image | |||
| width | 200px | |||
| image2 | 5-MeO-NMT 3D.png | |||
| image_class2 | bg-transparent | |||
| width2 | 200px | |||
| class | Serotonin receptor agonist; Serotonin 5-HT2A receptor agonist; Serotonin releasing agent | |||
| ATC_prefix | None | |||
| CAS_number_Ref | ||||
| CAS_number | 2009-03-2 | |||
| CAS_supplemental | (free base) | |||
| 2426-68-8 (hydrochloride) | ||||
| PubChem | 16184 | |||
| ChemSpiderID_Ref | ||||
| ChemSpiderID | 15360 | |||
| UNII_Ref | ||||
| UNII | YBO217L5YV | |||
| ChEBI_Ref | ||||
| ChEBI | 189635 | |||
| ChEMBL_Ref | ||||
| ChEMBL | 58579 | |||
| synonyms | 5-OMe-NMT; 5-Methoxy-*N*-methyltryptamine | |||
| IUPAC_name | 2-(5-methoxy-1*H*-indol-3-yl)-*N*-methylethan-1-amine | |||
| C | 12 | H=16 | N=2 | O=1 |
| SMILES | CNCCC1=CNC2=CC=C(C=C21)OC | |||
| StdInChI_Ref | ||||
| StdInChI | 1S/C12H16N2O/c1-13-6-5-9-8-14-12-4-3-10(15-2)7-11(9)12/h3-4,7-8,13-14H,5-6H2,1-2H3 | |||
| StdInChIKey_Ref | ||||
| StdInChIKey | NFDDCRIHMZGWBP-UHFFFAOYSA-N |
| Drugs.com =
| elimination_half-life =
2426-68-8 (hydrochloride)
5-MeO-NMT, also known as 5-methoxy-N-methyltryptamine, is an tryptamine alkaloid, being the 5-methoxy analogue of N-methyltryptamine (NMT). It was first isolated from Phalaris arundinacea (reed canary grass) and also occurs in other species such as Virola species and Bufo alvarius skin. The compound has been synthesized by Alexander Shulgin and reported in his book TiHKAL (Tryptamines I Have Known and Loved).
Use and effects
Alexander Shulgin included 5-MeO-NMT as an entry in his book TiHKAL (Tryptamines I Have Known and Loved). However, he does not appear to have tested it and states that the dose and duration of the compound are unknown. In any case, Shulgin stated that it would be expected to be rapidly metabolized by monoamine oxidase and that it would likely only be active parenterally.
Pharmacology
Pharmacodynamics
| Target | Affinity (Ki, nM) |
|---|---|
| [5-HT1A](5-ht1a-receptor) | 7.9 (Ki) |
| 1.1–220 () | |
| 72–111% () | |
| [5-HT1B](5-ht1b-receptor) | 23 |
| [5-HT1D](5-ht1d-receptor) | 3 |
| [5-HT1E](5-ht1e-receptor) | 212 |
| [5-HT2A](5-ht2a-receptor) | 79 (Ki) |
| 3.8–6.4 (EC50) | |
| 84–113% (Emax) | |
| [5-HT2B](5-ht2b-receptor) | 11 (Ki) |
| 8.8–12 (EC50) | |
| 94% (Emax) | |
| [5-HT2C](5-ht2c-receptor) | 116 (Ki) |
| 1.2–13 (EC50) | |
| 104% (Emax) | |
| [5-HT3](5-ht3-receptor) | IA |
| [5-HT5A](5-ht5a-receptor) | 60 |
| [5-HT6](5-ht6-receptor) | 25 |
| [5-HT7](5-ht7-receptor) | 7 |
| α2A | 1,543 |
| D4 | 885 |
| SERT | 1,114a (EC50) |
| 10,000a (EC50) | |
| 10,000a (EC50) | |
| **Notes:** The smaller the value, the more avidly the drug interacts with the site. **Footnotes:** a = Neurotransmitter release. **Sources: ** |
5-MeO-NMT is a potent agonist of the serotonin 5-HT1A, 5-HT2A, 5-HT2B, and 5-HT2C receptors. It is a full agonist or near-full agonist of all of these receptors except for the serotonin 5-HT1A receptor, where it is a partial agonist. It additionally displays a high affinity for multiple other serotonin receptors. The drug is also a very weak serotonin releasing agent and has sub micromolar affinity for dopamine D4 receptor.
There is conflicting data on its effects in mammals. In a study in 1964, Taborsky and McIsaac found 5-methoxy-NMT to have a 'moderately disruptive effect on conditioned behavior' in rats. Another study found it does not produce the head-twitch response, a behavioral proxy of psychedelic effects, in rodents, and in some cases even reduced total HTRs. On the other hand, it does induce serotonin 5-HT1A receptor-mediated hypothermia and hypolocomotion. Earlier reports had stated that 5-MeO-NMT and its N-demethylated analogue 5-methoxytryptamine were inactive, but this proved not to be the case.
Chemistry
Synthesis
The chemical synthesis of 5-MeO-NMT has been described.
Analogues
Notable analogues of 5-MeO-NMT include NMT, 5-MeO-NET, 5-MeO-NiPT, norpsilocin (4-HO-NMT), baeocystin (4-PO-NMT), 4-HO-NALT, and 5-MeO-NBpBrT, among others. 5-MeO-NMT is the N-monodemethylated analogue of 5-MeO-DMT.
Society and culture
Legal status
United States
In the United States, this substance is a Schedule 1 analogue of bufotenin.
References
References
- (1958). "428. 5-Methoxy-N-methyltryptamine: a new indole alkaloid from Phalaris arundinacea L.". Journal of the Chemical Society (Resumed).
- [http://www.erowid.org/library/books_online/tihkal/tihkal42.shtml 5-MeO-NMT Entry in ''TIHKAL'']
- (October 2014). "Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes". Psychopharmacology.
- (March 1964). "The relationship between the metabolic fate and pharmacological action of 5-methoxy-N-methyltryptamine". Biochemical Pharmacology.
- (December 2024). "Serotonin 1A Receptors Modulate Serotonin 2A Receptor-Mediated Behavioral Effects of 5-Methoxy-N,N-dimethyltryptamine Analogs in Mice". ACS Chemical Neuroscience.
- (1975). "Hallucinogenic Agents". Wright-Scientechnica.
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about 5-MeO-NMT — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report